Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Saudi FDA Wants Device & Drug Firms To Report Payments To Doctors, Health Institutions

Executive Summary

The Saudi Food and Drug Authority has finalized the details of a new transparency initiative under which medical device and pharmaceutical companies will have to disclose their financial relationships with health-care professionals and institutions. 

You may also be interested in...



When Do Device Companies Declare Payments To Professionals And Health-Care Organizations In Europe?

Europe recently saw a wave of disclosures published by pharmaceutical trade associations revealing the transfers of value made by companies to health-care professionals and organizations. In this article, attorneys at the law firm Baker & McKenzie – Julie Yeni, Julia Gillert, Chloe Cornet and Elina Angeloudi – discuss how the growing trend toward imposing greater transparency in the relationships between the health industry and health-care professionals continues, and what it will mean for the medical device sector in different countries across Europe and in Saudi Arabia.

Sunshine Website Goes Live With Some Context Sought By Industry

CMS releases data on $3.5 billion worth of payments made by drug and device companies to physicians and teaching hospitals in the last five months of 2013; an additional 199,000 payment records were not disclosed.

BioMarin’s Hemophilia Gene Therapy Among Nine Products On Track For EU-Wide Approval

Four orphan drugs and a new COVID-19 vaccine are among the latest products that the European Medicines Agency says should be approved.

Topics

Latest News
UsernamePublicRestriction

Register

MT122200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel